Viewing Study NCT05240859


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-26 @ 2:27 AM
Study NCT ID: NCT05240859
Status: UNKNOWN
Last Update Posted: 2022-02-15
First Post: 2022-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis
Sponsor: Peking University People's Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-02-22
Start Date Type: ESTIMATED
Primary Completion Date: 2024-02-28
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-08-30
Completion Date Type: ESTIMATED
First Submit Date: 2022-02-06
First Submit QC Date: None
Study First Post Date: 2022-02-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-06
Last Update Post Date: 2022-02-15
Last Update Post Date Type: ACTUAL